ReviewSexually transmitted infections2023

Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea.

Nicole E Scangarella-Oman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.